{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ00619",
      "entity_text" : "nitric\noxide",
      "entity_type" : "simple_chemical"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:PDE",
      "entity_text" : "phosphodiesterase",
      "entity_type" : "family"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Another option in the treatment of DO is Tadafila, which is a selective inhibitor of phosphodiesterase type 5 (PDE-5) that potentiates the action of nitric oxide (NO) at a concentration of 4mg/kg XREF_BIBR.",
  "reading_complete" : "2020-08-05T19:07:56Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-05T19:07:20Z",
  "trigger" : "potentiates",
  "evidence" : [ "phosphodiesterase type 5 (PDE-5) that potentiates the action of nitric\noxide" ],
  "pmc_id" : "6585915",
  "score" : 0
}